本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 1994/8/161 分钟阅读
National Eye Institute; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Child Health and Human Development; Licensing Opportunity and/or Opportunity for a Cooperative Research and Development Agreement (CRADA) for the Use of Antiflammins
本地自动翻译 · 来源原始语言
摘要
The National Institutes of Health is seeking licensees and/or CRADA partners for the further development and commercialization of its patent portfolio for antiflammins. The inventions claimed in the following patent applications are available for either exclusive or non-exclusive licensing (in accordance with 35 U.S.C. 207 and 37 CFR Part 404) and/or further development under one or more CRADAs in several clinically important applications as described below in the Supplementary Information:
来源原始语言: Federal Register — Health and Human Services打开原始公告 →